VEGFA and chronic kidney disease: For example, statistically significant rises in plasma vascular endothelial growth factor (VEGF) levels were observed when relatively high doses of daprodustat (50–100 mg) were given to healthy subjects but were not detected with lower doses sufficient to maintain Hb in CKD patients.